ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................
J
BDM Ver 2.0.14 (4th of August) - 2999001/0
The file contains technical information submitted after the application was filed and not included in this specification
3552615
CORRECTED EUROPEAN PATENT SPECIFICATION
B8
B1
20220302
W1
73
de
Bibliographie
en
Bibliography
fr
Bibliographie
EP
19174121.4
20150716
20200403
20200818
en
en
en
14306153
20140716
EP
20220302
202209
20191016
201942
20220126
202204
20210915
20220302
202209
A61K 35/768 20150101AFI20210817BHEP
C07K 16/18 20060101ALI20210817BHEP
A61K 35/765 20150101ALI20210817BHEP
A61K 9/00 20060101ALI20210817BHEP
A61K 47/02 20060101ALI20210817BHEP
A61K 9/08 20060101ALI20210817BHEP
A61K 35/761 20150101ALI20210817BHEP
A61K 35/763 20150101ALI20210817BHEP
A61K 35/766 20150101ALI20210817BHEP
C07K 14/535 20060101ALI20210817BHEP
C07K 16/28 20060101ALI20210817BHEP
C12N 9/10 20060101ALI20210817BHEP
C12N 9/80 20060101ALI20210817BHEP
A61K 45/06 20060101ALI20210817BHEP
A61K 35/765 20130101 LI20160422BHEP
A61K 35/761 20130101 LI20160422BHEP
A61K 35/763 20130101 LI20160422BHEP
A61K 35/766 20130101 LI20160422BHEP
C07K2317/76 20130101 LA20180724BHEP
A61K 47/02 20130101 LI20180726BHEP
A61K 9/08 20130101 LI20180726BHEP
A61K 35/768 20130101 FI20170608BHEP
A61K 9/0019 20130101 LI20170608BHEP
A61K2039/505 20130101 LA20170608BHEP
C07K 14/535 20130101 LI20170608BHEP
C07K 16/2818 20130101 LI20170608BHEP
C07K2317/55 20130101 LA20170608BHEP
C07K2317/622 20130101 LA20170608BHEP
C12N 9/1077 20130101 LI20170608BHEP
C12N 9/80 20130101 LI20170608BHEP
C12N2710/24121 20130101 LA20170608BHEP
C12N2710/24132 20130101 LA20170608BHEP
C12Y 204/02009 20130101 LI20170608BHEP
C12Y 305/01023 20130101 LI20170608BHEP
A61P 1/00 20180101 LI20200318BHEP
A61P 1/16 20180101 LI20200318BHEP
A61P 11/00 20180101 LI20200318BHEP
A61P 13/08 20180101 LI20200319BHEP
A61P 13/12 20180101 LI20200319BHEP
A61P 35/00 20180101 LI20200327BHEP
de
ONKOLYTISCHES VIRUS ZUR EXPRESSION VON IMMUNOLOGISCHEN PRÜFPUNKTMODULATOREN
en
ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS
fr
VIRUS ONCOLYTIQUE POUR L'EXPRESSION DE MODULATEURS DE POINT DE CONTRÔLE IMMUNITAIRE
WO-A1-2009/065546
WO-A1-2014/047350
WO-A1-2019/178101
WO-A1-2020/049001
CN-A- 108 165 536
CN-A- 110 218 707
J D DIAS ET AL: "Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4", GENE THERAPY, 10 November 2011 (2011-11-10), XP055015331, ISSN: 0969-7128, DOI: 10.1038/gt.2011.176
J. D. DIAS ET AL: "Targeted Chemotherapy for Head and Neck Cancer with a Chimeric Oncolytic Adenovirus Coding for Bifunctional Suicide Protein FCU1", CLINICAL CANCER RESEARCH, vol. 16, no. 9, 13 April 2010 (2010-04-13) , pages 2540-2549, XP055214478, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-09-2974
T DU ET AL: "Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers", CANCER GENE THERAPY, vol. 21, no. 8, 18 July 2014 (2014-07-18), pages 340-348, XP055214039, ISSN: 0929-1903, DOI: 10.1038/cgt.2014.34
CHRISTINE E ENGELAND ET AL: "CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy", MOLECULAR THERAPY, vol. 22, no. 11, 26 August 2014 (2014-08-26), pages 1949-1959, XP055158410, ISSN: 1525-0016, DOI: 10.1038/mt.2014.160
MAXINE BAUZON ET AL: "Armed Therapeutic Viruses - A Disruptive Therapy on the Horizon of Cancer Immunotherapy", FRONTIERS IN IMMUNOLOGY, vol. 5, 1 February 2014 (2014-02-01), XP055214432, DOI: 10.3389/fimmu.2014.00074
DON B GAMMON ET AL: "Vaccinia Virus-Encoded Ribonucleotide Reductase Subunits Are Differentially Required for Replication and Pathogenesis", PL O S PATHOGENS (PRINT), PUBLIC LIBRARY OF SCIENCE, US, vol. 6, no. 7, 8 July 2010 (2010-07-08), pages e1000984-1, XP008150295, ISSN: 1553-7366, DOI: 10.1371/JOURNAL.PPAT.1000984
KYLE G. POTTS ET AL: "Oncolytic Viruses in the Treatment of Bladder Cancer", ADVANCES IN UROLOGY, vol. 2012, 1 January 2012 (2012-01-01), pages 1-11, XP055443442, ISSN: 1687-6369, DOI: 10.1155/2012/404581
WOO YANGHEE ET AL: "Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer", JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, COLLEGE, CHICAGO, IL, US, vol. 230, no. 4, 4 February 2020 (2020-02-04), pages 709-717, XP086103159, ISSN: 1072-7515, DOI: 10.1016/J.JAMCOLLSURG.2019.12.027 [retrieved on 2020-02-04]
15738359.7
3169341
20150716
SILVESTRE, Nathalie
6, rue des Iris
67120 ERGERSHEIM
FR
GEIST, Michel
18, rue Edouard Manet
67170 BRUMATH
FR
RITTNER, Karola
51, rue des Pluviers
67100 STRASBOURG
FR
MARCHAND, Jean-Baptiste
1A rue des Hauts Pâturages
67210 OBERNAI
FR
THIOUDELLET, Christine
4, boulevard de la Victoire
67000 STRASBOURG
FR
TRANSGENE
101839187
B75262EPD35114
Parc d'Innovation Boulevard Gonthier d'Andernach
67400 Illkirch Graffenstaden
FR
Regimbeau
101326519
20, rue de Chazelles
75847 Paris Cedex 17
FR
AL
AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HR
HU
IE
IS
IT
LI
LT
LU
LV
MC
MK
MT
NL
NO
PL
PT
RO
RS
SE
SI
SK
SM
TR